Cheryl Gault

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cheryl Gault:

Company Role Class Num Shares Value Price $ Report Date Ownership
Rapport Therapeutics, Inc. Chief Operating Officer Common Stock 171,928 $5,174,568 $30.10 26 Nov 2025 Direct
Cyclerion Therapeutics, Inc. Chief Operating Officer Employee Stock Option (Right to Buy) 135,000 20 Jan 2022 Direct
Rapport Therapeutics, Inc. Chief Operating Officer Stock Option (Right to Buy) 105,407 26 Nov 2025 Direct

Insider Reports Filed by Cheryl Gault

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RAPP Rapport Therapeutics, Inc. 26 Nov 2025 3 -$141,486 4 Chief Operating Officer 01 Dec 2025, 16:17
RAPP Rapport Therapeutics, Inc. 08 Sep 2025 3 -$182,650 4 Chief Operating Officer 10 Sep 2025, 16:15
RAPP Rapport Therapeutics, Inc. 03 Mar 2025 1 $0 4 Chief Operating Officer 05 Mar 2025, 17:00
RAPP Rapport Therapeutics, Inc. 03 Feb 2025 1 $0 4 Chief Operating Officer 04 Feb 2025, 17:30
RAPP Rapport Therapeutics, Inc. 06 Jun 2024 1 $0 4 Chief Operations Officer 10 Jun 2024, 19:43
RAPP Rapport Therapeutics, Inc. 06 Jun 2024 0 $0 3 Chief Operations Officer 06 Jun 2024, 19:04
CYCN Cyclerion Therapeutics, Inc. 20 Jan 2022 1 $0 4 Chief Operating Officer 24 Jan 2022, 10:33
CYCN Cyclerion Therapeutics, Inc. 09 Dec 2021 1 $0 4 Chief Operating Officer 10 Dec 2021, 15:31